Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice

Treatment with galantide alone ameliorated most of the indices of AP studied, whereas treatment with octreotide reduced pancreatic MPO activity and acinar cell damage. Combining the two peptides appears to negate their individual benefits, which suggests an interaction in their mechanism of action.